Atlas Venture Fund VIII, L.P.

Related Filers (6)

Other (10)

13F-NT
Friday, 2/2/2024
Initial Quarterly Form 13F Notice Report filed by institutional managers
144
Monday, 1/29/2024
Filing for proposed sale of securities under Rule 144
13F-NT
Monday, 11/13/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 8/8/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/8/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 1/31/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Thursday, 11/10/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Thursday, 8/11/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Thursday, 5/12/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Thursday, 1/27/2022
Initial Quarterly Form 13F Notice Report filed by institutional managers
Show More

Ownership (10)

SC 13G/A
Tuesday, 1/31/2023
INTEGRAL AD SCIENCE HOLDING CORP.: Major Shareholders
SC 13G
Monday, 2/7/2022
INTEGRAL AD SCIENCE HOLDING CORP.: Major Shareholders
3
Tuesday, 6/29/2021
INTEGRAL AD SCIENCE HOLDING CORP.: Initial statement of beneficial ownership of securities
SC 13G/A
Tuesday, 2/2/2021
Translate Bio, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/2/2021
BICYCLE THERAPEUTICS plc: Major Shareholders
SC 13G
Tuesday, 2/4/2020
BICYCLE THERAPEUTICS plc: Major Shareholders
SC 13G/A
Tuesday, 2/4/2020
Translate Bio, Inc.: Major Shareholders
SC 13G
Friday, 2/8/2019
Translate Bio, Inc.: Major Shareholders
4
Tuesday, 7/3/2018
Translate Bio, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/27/2018
Translate Bio, Inc.: Initial statement of beneficial ownership of securities
Show More